Skip to main content
Erschienen in: Diabetologia 4/2018

28.11.2017 | Article

Plasma concentrations of 8-hydroxy-2′-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes

verfasst von: Manuel Sanchez, Ronan Roussel, Samy Hadjadj, Abdul Moutairou, Michel Marre, Gilberto Velho, Kamel Mohammedi

Erschienen in: Diabetologia | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Oxidative stress is involved in the pathogenesis of diabetic kidney disease. We evaluated the association between 8-hydroxy-2′-deoxyguanosine (8-OHdG), a marker of DNA oxidative damage, and end-stage renal disease (ESRD) or death in individuals with type 1 diabetes.

Methods

Plasma 8-OHdG concentrations were measured at baseline in participants with type 1 diabetes from GENEDIAB (n = 348) and GENESIS (n = 571) cohorts. A follow-up was conducted in 205 and 499 participants for a mean ± SD duration of 8.9 ± 2.3 years and 5.2 ± 1.9 years, respectively. We tested associations between 8-OHdG concentrations and urinary albumin concentration (UAC) or eGFR at baseline, and the risk of ESRD or all-cause mortality during follow-up. Analyses were performed in pooled cohorts.

Results

The highest UAC (geometric mean [95% CI]) was observed in the third 8-OHdG tertile (tertile 1, 9 [6, 13] mg/l; tertile 2, 10 [7, 16] mg/l; tertile 3, 16 [10, 25] mg/l; p = 0.36 for tertile 1 vs tertile 2 and p = 0.003 for tertile 3 vs tertile 1) after adjustment for potential confounding covariates. The lowest eGFR (mean [95% CI]) was observed in the third tertile (tertile 1, 87 [82, 93] ml min−1 1.73 m−2; tertile 2, 88 [82, 94] ml min−1 1.73 m−2; tertile 3, 74 [68, 80] ml min−1 1.73 m−2; p = 0.61 for tertile 1 vs tertile 2; p < 0.001 for tertile 3 vs tertile 1). ESRD and death occurred in 48 and 64 individuals, respectively. The HR for ESRD, but not death, was higher in the third tertile than in the first (tertile 2 vs tertile 1, 1.45 [0.45, 5.04], p = 0.54; tertile 3 vs tertile 1, 3.05 [1.16, 9.60], p = 0.02) after multiple adjustments.

Conclusions/interpretation

Higher plasma concentrations of 8-OHdG were independently associated with increased risk of kidney disease in individuals with type 1 diabetes, suggesting that this marker can be used to evaluate the progression of diabetic kidney disease.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Orchard TJ, Secrest AM, Miller RG, Costacou T (2010) In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 53:2312–2319CrossRefPubMedPubMedCentral Orchard TJ, Secrest AM, Miller RG, Costacou T (2010) In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 53:2312–2319CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat de Boer IH, Rue TC, Cleary PA et al (2011) Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med 171:412–420CrossRefPubMedPubMedCentral de Boer IH, Rue TC, Cleary PA et al (2011) Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med 171:412–420CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Stadler M, Peric S, Strohner-Kaestenbauer H et al (2014) Mortality and incidence of renal replacement therapy in people with type 1 diabetes mellitus—a three decade long prospective observational study in the Lainz T1DM cohort. J Clin Endocrinol Metab 99:4523–4530CrossRefPubMed Stadler M, Peric S, Strohner-Kaestenbauer H et al (2014) Mortality and incidence of renal replacement therapy in people with type 1 diabetes mellitus—a three decade long prospective observational study in the Lainz T1DM cohort. J Clin Endocrinol Metab 99:4523–4530CrossRefPubMed
4.
5.
Zurück zum Zitat Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625CrossRefPubMed Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625CrossRefPubMed
6.
Zurück zum Zitat Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820CrossRefPubMed Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820CrossRefPubMed
7.
Zurück zum Zitat Forbes JM, Coughlan MT, Cooper ME (2008) Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57:1446–1454CrossRefPubMed Forbes JM, Coughlan MT, Cooper ME (2008) Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57:1446–1454CrossRefPubMed
8.
Zurück zum Zitat Coughlan MT, Mibus AL, Forbes JM (2008) Oxidative stress and advanced glycation in diabetic nephropathy. Ann N Y Acad Sci 1126:190–193CrossRefPubMed Coughlan MT, Mibus AL, Forbes JM (2008) Oxidative stress and advanced glycation in diabetic nephropathy. Ann N Y Acad Sci 1126:190–193CrossRefPubMed
10.
Zurück zum Zitat Mohammedi K, Patente TA, Bellili-Munoz N et al (2013) Catalase activity, allelic variations in the catalase gene and risk of kidney complications in patients with type 1 diabetes. Diabetologia 56:2733–2742CrossRefPubMed Mohammedi K, Patente TA, Bellili-Munoz N et al (2013) Catalase activity, allelic variations in the catalase gene and risk of kidney complications in patients with type 1 diabetes. Diabetologia 56:2733–2742CrossRefPubMed
11.
Zurück zum Zitat Patente TA, Mohammedi K, Bellili-Munoz N et al (2015) Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes. Free Radic Biol Med 86:16–24CrossRefPubMed Patente TA, Mohammedi K, Bellili-Munoz N et al (2015) Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes. Free Radic Biol Med 86:16–24CrossRefPubMed
13.
Zurück zum Zitat Du XL, Edelstein D, Rossetti L et al (2000) Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97:12222–12226CrossRefPubMedPubMedCentral Du XL, Edelstein D, Rossetti L et al (2000) Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97:12222–12226CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Grishko V, Pastukh V, Solodushko V, Gillespie M, Azuma J, Schaffer S (2003) Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: role of DNA damage. Am J Physiol Heart Circ Physiol 285:H2364–H2372CrossRefPubMed Grishko V, Pastukh V, Solodushko V, Gillespie M, Azuma J, Schaffer S (2003) Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: role of DNA damage. Am J Physiol Heart Circ Physiol 285:H2364–H2372CrossRefPubMed
15.
Zurück zum Zitat Ricci C, Pastukh V, Leonard J et al (2008) Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis. Am J Phys Cell Phys 294:C413–C422CrossRef Ricci C, Pastukh V, Leonard J et al (2008) Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis. Am J Phys Cell Phys 294:C413–C422CrossRef
17.
Zurück zum Zitat Cooke MS, Evans MD, Herbert KE, Lunec J (2000) Urinary 8-oxo-2′-deoxyguanosine—source, significance and supplements. Free Radic Res 32:381–397CrossRefPubMed Cooke MS, Evans MD, Herbert KE, Lunec J (2000) Urinary 8-oxo-2′-deoxyguanosine—source, significance and supplements. Free Radic Res 32:381–397CrossRefPubMed
18.
Zurück zum Zitat Dandona P, Thusu K, Cook S et al (1996) Oxidative damage to DNA in diabetes mellitus. Lancet 347:444–445CrossRefPubMed Dandona P, Thusu K, Cook S et al (1996) Oxidative damage to DNA in diabetes mellitus. Lancet 347:444–445CrossRefPubMed
19.
Zurück zum Zitat Leinonen J, Lehtimaki T, Toyokuni S et al (1997) New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 417:150–152CrossRefPubMed Leinonen J, Lehtimaki T, Toyokuni S et al (1997) New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 417:150–152CrossRefPubMed
20.
Zurück zum Zitat Hinokio Y, Suzuki S, Hirai M, Chiba M, Hirai A, Toyota T (1999) Oxidative DNA damage in diabetes mellitus: its association with diabetic complications. Diabetologia 42:995–998CrossRefPubMed Hinokio Y, Suzuki S, Hirai M, Chiba M, Hirai A, Toyota T (1999) Oxidative DNA damage in diabetes mellitus: its association with diabetic complications. Diabetologia 42:995–998CrossRefPubMed
21.
Zurück zum Zitat Shin CS, Moon BS, Park KS et al (2001) Serum 8-hydroxy-guanine levels are increased in diabetic patients. Diabetes Care 24:733–737CrossRefPubMed Shin CS, Moon BS, Park KS et al (2001) Serum 8-hydroxy-guanine levels are increased in diabetic patients. Diabetes Care 24:733–737CrossRefPubMed
22.
Zurück zum Zitat Xu GW, Yao QH, Weng QF, Su BL, Zhang X, Xiong JH (2004) Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients. J Pharm Biomed Anal 36:101–104CrossRefPubMed Xu GW, Yao QH, Weng QF, Su BL, Zhang X, Xiong JH (2004) Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients. J Pharm Biomed Anal 36:101–104CrossRefPubMed
23.
Zurück zum Zitat Marre M, Jeunemaitre X, Gallois Y et al (1997) Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest 99:1585–1595CrossRefPubMedPubMedCentral Marre M, Jeunemaitre X, Gallois Y et al (1997) Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest 99:1585–1595CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Hadjadj S, Pean F, Gallois Y et al (2004) Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study. Diabetes Care 27:2661–2668CrossRefPubMed Hadjadj S, Pean F, Gallois Y et al (2004) Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study. Diabetes Care 27:2661–2668CrossRefPubMed
25.
Zurück zum Zitat Kohner EM (1991) The lesions and natural history of diabetic retinopathy. In: Pickup J, Williams G (eds) Textbook of diabetes. Blackwell Scientific, Oxford, pp 575–588 Kohner EM (1991) The lesions and natural history of diabetic retinopathy. In: Pickup J, Williams G (eds) Textbook of diabetes. Blackwell Scientific, Oxford, pp 575–588
26.
Zurück zum Zitat Witko-Sarsat V, Friedlander M, Capeillere-Blandin C et al (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304–1313CrossRefPubMed Witko-Sarsat V, Friedlander M, Capeillere-Blandin C et al (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304–1313CrossRefPubMed
27.
Zurück zum Zitat KDIGO Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 3:1–150CrossRef KDIGO Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 3:1–150CrossRef
28.
Zurück zum Zitat Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509CrossRef Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509CrossRef
29.
Zurück zum Zitat Broedbaek K, Siersma V, Henriksen T et al (2011) Urinary markers of nucleic acid oxidation and long-term mortality of newly diagnosed type 2 diabetic patients. Diabetes Care 34:2594–2596CrossRefPubMedPubMedCentral Broedbaek K, Siersma V, Henriksen T et al (2011) Urinary markers of nucleic acid oxidation and long-term mortality of newly diagnosed type 2 diabetic patients. Diabetes Care 34:2594–2596CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Tarng DC, Huang TP, Wei YH et al (2000) 8-Hydroxy-2′-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Am J Kidney Dis 36:934–944CrossRefPubMed Tarng DC, Huang TP, Wei YH et al (2000) 8-Hydroxy-2′-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Am J Kidney Dis 36:934–944CrossRefPubMed
31.
Zurück zum Zitat Tarng DC, Wen Chen T, Huang TP, Chen CL, Liu TY, Wei YH (2002) Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients. J Am Soc Nephrol 13:1321–1330CrossRefPubMed Tarng DC, Wen Chen T, Huang TP, Chen CL, Liu TY, Wei YH (2002) Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients. J Am Soc Nephrol 13:1321–1330CrossRefPubMed
32.
Zurück zum Zitat Hinokio Y, Suzuki S, Hirai M, Suzuki C, Suzuki M, Toyota T (2002) Urinary excretion of 8-oxo-7, 8-dihydro-2′-deoxyguanosine as a predictor of the development of diabetic nephropathy. Diabetologia 45:877–882CrossRefPubMed Hinokio Y, Suzuki S, Hirai M, Suzuki C, Suzuki M, Toyota T (2002) Urinary excretion of 8-oxo-7, 8-dihydro-2′-deoxyguanosine as a predictor of the development of diabetic nephropathy. Diabetologia 45:877–882CrossRefPubMed
33.
Zurück zum Zitat Mishra M, Lillvis J, Seyoum B, Kowluru RA (2016) Peripheral blood mitochondrial DNA damage as a potential noninvasive biomarker of diabetic retinopathy. Invest Ophthalmol Vis Sci 57:4035–4044CrossRefPubMedPubMedCentral Mishra M, Lillvis J, Seyoum B, Kowluru RA (2016) Peripheral blood mitochondrial DNA damage as a potential noninvasive biomarker of diabetic retinopathy. Invest Ophthalmol Vis Sci 57:4035–4044CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Shi XY, Hou FF, Niu HX et al (2008) Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology 149:1829–1839CrossRefPubMed Shi XY, Hou FF, Niu HX et al (2008) Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology 149:1829–1839CrossRefPubMed
35.
Zurück zum Zitat Wei XF, Zhou QG, Hou FF, Liu BY, Liang M (2009) Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase. Am J Physiol Ren Physiol 296:F427–F437CrossRef Wei XF, Zhou QG, Hou FF, Liu BY, Liang M (2009) Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase. Am J Physiol Ren Physiol 296:F427–F437CrossRef
36.
Zurück zum Zitat Mohammedi K, Bellili-Munoz N, Driss F et al (2014) Manganese superoxide dismutase (SOD2) polymorphisms, plasma advanced oxidation protein products (AOPP) concentration and risk of kidney complications in subjects with type 1 diabetes. PLoS One 9:e96916CrossRefPubMedPubMedCentral Mohammedi K, Bellili-Munoz N, Driss F et al (2014) Manganese superoxide dismutase (SOD2) polymorphisms, plasma advanced oxidation protein products (AOPP) concentration and risk of kidney complications in subjects with type 1 diabetes. PLoS One 9:e96916CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Kakimoto M, Inoguchi T, Sonta T et al (2002) Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats. Diabetes 51:1588–1595CrossRefPubMed Kakimoto M, Inoguchi T, Sonta T et al (2002) Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats. Diabetes 51:1588–1595CrossRefPubMed
38.
Zurück zum Zitat Simone S, Gorin Y, Velagapudi C, Abboud HE, Habib SL (2008) Mechanism of oxidative DNA damage in diabetes: tuberin inactivation and downregulation of DNA repair enzyme 8-oxo-7,8-dihydro-2′-deoxyguanosine-DNA glycosylase. Diabetes 57:2626–2636CrossRefPubMedPubMedCentral Simone S, Gorin Y, Velagapudi C, Abboud HE, Habib SL (2008) Mechanism of oxidative DNA damage in diabetes: tuberin inactivation and downregulation of DNA repair enzyme 8-oxo-7,8-dihydro-2′-deoxyguanosine-DNA glycosylase. Diabetes 57:2626–2636CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Qi H, Casalena G, Shi S et al (2017) Glomerular endothelial mitochondrial dysfunction is essential and characteristic of diabetic kidney disease susceptibility. Diabetes 66:763–778CrossRefPubMed Qi H, Casalena G, Shi S et al (2017) Glomerular endothelial mitochondrial dysfunction is essential and characteristic of diabetic kidney disease susceptibility. Diabetes 66:763–778CrossRefPubMed
Metadaten
Titel
Plasma concentrations of 8-hydroxy-2′-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes
verfasst von
Manuel Sanchez
Ronan Roussel
Samy Hadjadj
Abdul Moutairou
Michel Marre
Gilberto Velho
Kamel Mohammedi
Publikationsdatum
28.11.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 4/2018
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-017-4510-1

Weitere Artikel der Ausgabe 4/2018

Diabetologia 4/2018 Zur Ausgabe

List of Referees

Referees 2017

Up Front

Up front

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.